Mitsubishi UFJ Asset Management
ATRA icon

Mitsubishi UFJ Asset Management’s Atara Biotherapeutics ATRA Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,480
Closed -$180K – 1110
2023
Q1 		$180K Hold
2,480
– – ﹤0.01% 1033
2022
Q4 		$203K Buy
2,480
+522
+27% +$54.4K ﹤0.01% 1016
2022
Q3 		$185K Buy
1,958
+37
+2% +$4.16K ﹤0.01% 1033
2022
Q2 		$374K Buy
1,921
+1,232
+179% +$201K ﹤0.01% 968
2022
Q1 		$160K Buy
689
+44
+7% +$14K ﹤0.01% 1085
2021
Q4 		$272K Sell
645
-227
-26% -$95.6K ﹤0.01% 1030
2021
Q3 		$390K Buy
872
+23
+3% +$8.24K ﹤0.01% 974
2021
Q2 		$330K Buy
849
+186
+28% +$66.3K ﹤0.01% 1023
2021
Q1 		$238K Buy
663
+199
+43% +$88K ﹤0.01% 974
2020
Q4 		$228K Sell
464
-221
-32% -$102K ﹤0.01% 941
2020
Q3 		$222K Sell
685
-1
-0.1% -$341 ﹤0.01% 886
2020
Q2 		$250K Buy
686
+193
+39% +$48.8K ﹤0.01% 858
2020
Q1 		$105K Buy
493
+89
+22% +$28.2K ﹤0.01% 929
2019
Q4 		$162K Buy
404
+171
+73% +$59K ﹤0.01% 906
2019
Q3 		$82K Buy
233
+34
+17% +$12.7K ﹤0.01% 922
2019
Q2 		$100K Buy
199
+17
+9% +$12K ﹤0.01% 917
2019
Q1 		$181K Buy
182
+20
+12% +$18.6K ﹤0.01% 811
2018
Q4 		$115K Buy
162
+39
+32% +$36.2K ﹤0.01% 828
2018
Q3 		$127K Buy
+123
New +$120K ﹤0.01% 824

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mitsubishi UFJ Asset Management's ATRA Position: Q2 2023 in Review

Mitsubishi UFJ Asset Management sold out of Atara Biotherapeutics (ATRA) in Q2 2023, closing a stake of 2,480 shares — an estimated $180K sold.

Mitsubishi UFJ Asset Management first reported a position in ATRA in Q3 2018 and held it in 19 quarters. The position peaked at $390K in Q3 2021. 118 funds tracked by Wall St. Rank hold ATRA as of Q2 2023.

  • Mitsubishi UFJ Asset Management reported no remaining Atara Biotherapeutics position as of Q2 2023 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 2,480 Atara Biotherapeutics shares in Q2 2023, an estimated $180K.
  • Mitsubishi UFJ Asset Management first reported a position in Atara Biotherapeutics in Q3 2018 and held it in 19 quarters.
  • Mitsubishi UFJ Asset Management's Atara Biotherapeutics position peaked at $390K in Q3 2021.
  • 118 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2023.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.